John Leppert

Director, Urologic Oncology at the VA Palo Alto Health Care System · Stanford Health Care

Credentials: · · ·

History

VA Palo Alto Health Care System Division · Stanford Health Care
Present
Stanford Health Care
Present
Stanford Health Care
Present

University of California-Los Angeles
2007–2008
Urology
UCLA David Geffen School of Medicine/UCLA Medical Center
2002–2007
University of California-Los Angeles
2001–2004
Doctor of Medicine
1997–2001

Research

Organoid Modeling of the Tumor Immune Microenvironment
Cell · 2018 · 1,265 citations
Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy
Cancer · 2007 · 294 citations
Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy
Review · The Journal of Urology · 2005 · 275 citations

Glenn Chertow
34 papers
Alan Pao
31 papers
James Brooks
31 papers
Benjamin Chung
25 papers
Calyani Ganesan
23 papers · 2 as a fellow
Arie Belldegrun
22 papers
Simon Conti
22 papers · 1 as a resident
Joseph Liao
19 papers · 13 as a resident
Christopher Elliott
16 papers · 1 as a fellow
JL
John Lam
14 papers · 14 as a resident
Ted Skolarus
14 papers
TM
Thomas Metznar
13 papers · 3 as a resident

Grants

Integration of Life Expectancy Estimates into Electronic Health Record Decision Support for Men with Prostate Cancer
National Cancer Institute · R01
PI · $574.6K · Cedars-Sinai Medical Center
2026–2031
Defining Optimal Care for Urinary Stone Disease in the Veterans Health Administration
Department of Veterans Affairs · I01
PI · Veterans Admin Palo Alto Health Care Sys
2020–2025
(PQ8) Biomarker Identification by Mass Cytometry in Peripheral Blood of Patients with Renal Cell Carcinoma Undergoing Immune Checkpoint Therapy
National Cancer Institute · R21
PI · $377.3K · Stanford University
2019–2021
Personalized Life Expectancy to Encourage High Value Prostate Cancer Care
Department of Veterans Affairs · I01
Contact PI · Veterans Admin Palo Alto Health Care Sys
2017–2021